Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02088047 · ClinicalTrials.gov registry record · NA
The Effects of ProFoveate on Reducing Self-Stimulating Behaviors
A NA study, sponsored by University of Arkansas.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT02088047 is a NA study that was terminated before completion, run by University of Arkansas. The registered enrollment target is 4 participants.
The verdict
NCT02088047, a NA study, was terminated before completion, sponsored by University of Arkansas.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
This study is designed to pilot an intervention technique to reduce the self-stimulating behaviors seen in individuals with autism spectrum disorders using intervention with ProFoveate pellets. Self-stimulating behaviors like hand flapping, eye blinking, and rocking, can interfere with the individual's ability to interact with their peers. Participants will wear the pellets for four week and measures with taken again. Another group of participants will not get the pellets. Both groups will be tested at the beginning and end of the study. Any variations in self-stimulating behaviors will be documented through parent report, Observational data. The investigators hypothesize that they will see changes in self- stimulating behaviors as a result of the strategic placement of the ProFoveate™ pellets on the ears of one group of the participants.
Interventions
- DEVICE ProFoveate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2014-08-30 |
| Est. Completion | 2018-10-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02088047
The ClinicalTrials.gov registry entry for NCT02088047 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ProFoveate is the first listed.
NCT02088047 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02088047 about?
NCT02088047 is a clinical study titled "The Effects of ProFoveate on Reducing Self-Stimulating Behaviors". This study is designed to pilot an intervention technique to reduce the self-stimulating behaviors seen in individuals with autism spectrum disorders using intervention with ProFoveate pellets. Self-stimulating behaviors like hand flapping, eye blinking, and rocking, can interfere with the individua...
What is the current status of trial NCT02088047?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2014-08-30. Estimated completion is 2018-10-04.
What interventions are being tested in trial NCT02088047?
The interventions under investigation include: ProFoveate (DEVICE).
Who is sponsoring clinical trial NCT02088047?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.